4//SEC Filing
Deck Kelly 4
Accession 0001739614-24-000023
CIK 0001739614other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 4:57 PM ET
Size
7.7 KB
Accession
0001739614-24-000023
Insider Transaction Report
Form 4
Inhibrx, Inc.INBX
Deck Kelly
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-05-06$34.24/sh−17,624$603,446→ 0 totalExercise: $10.52Exp: 2028-11-26→ Common Stock (17,624 underlying) - Exercise/Conversion
Stock Option (right to buy)
2024-05-06$34.24/sh−2,087$71,459→ 0 totalExercise: $11.25Exp: 2030-04-21→ Common Stock (2,087 underlying)
Footnotes (2)
- [F1]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on November 26, 2019, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
- [F2]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on April 21, 2021, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
Documents
Issuer
Inhibrx, Inc.
CIK 0001739614
Entity typeother
Related Parties
1- filerCIK 0001819427
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 4:57 PM ET
- Size
- 7.7 KB